Status:
UNKNOWN
Effect of Taurine on Glycemic Control in Type I and Type II Diabetic Patients
Lead Sponsor:
Hamad Medical Corporation
Conditions:
it is a Group of Metabolic Diseases in
Which a Person Has High Blood Sugar, Either
Eligibility:
All Genders
18-60 years
Phase:
PHASE1
PHASE2
Brief Summary
Diabetes mellitus (DM) and its vascular complications are the one of the most prevalent diseases in the state of Qatar. It is a multifactorial disease associated with the development of retinopathy, n...
Eligibility Criteria
Inclusion
- Male or Female
- Above 18-65 Years of old
- Known diabetic patients with HbA1c\>8.0%
- People who provide signed informed consent -
Exclusion
- 1\. Pregnancy 2. Diabetic patients with HbA1c \<8.0 % 3. Recent or prospective surgical interventions 4. Complications of Type I and Type II DM, e.g., Active cardiovascular disease, nephropathy, retinopathy, neuropathy 5. People who do not provide signed informed consent
Key Trial Info
Start Date :
November 1 2012
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2014
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT01226537
Start Date
November 1 2012
End Date
December 1 2014
Last Update
November 9 2012
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.